See more : Innate Pharma S.A. (IPHA) Income Statement Analysis – Financial Results
Complete financial analysis of Bellavista Resources Limited (BVR.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Bellavista Resources Limited, a leading company in the Industrial Materials industry within the Basic Materials sector.
- Greenyn Biotechnology Co., Ltd (6846.TWO) Income Statement Analysis – Financial Results
- Bank of America Corporation (BAC-PO) Income Statement Analysis – Financial Results
- BCE Inc. (BCEXF) Income Statement Analysis – Financial Results
- Umicore SA (NVJP.DE) Income Statement Analysis – Financial Results
- Grupo Mexicano de Desarrollo, S.A.B. (GMD.MX) Income Statement Analysis – Financial Results
Bellavista Resources Limited (BVR.AX)
About Bellavista Resources Limited
Bellavista Resources Limited operates as a mineral exploration company. The company has tenement package that covers approximately 100 kilometers of the northern margin of the Edmund Basin. Its projects include Brumby Deposit, Vernon Base Metals, Vernon Nickel-PGE, and Gorge Creek, which are prospective for zinc, copper, silver, PGE, and uranium deposits. The company was incorporated in 2021 and is based in West Perth, Australia.
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 64.82K | 79.86K | 0.00 |
| Cost of Revenue | 0.00 | 11.36K | 43.00 |
| Gross Profit | 64.82K | 68.50K | -43.00 |
| Gross Profit Ratio | 100.00% | 85.77% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 |
| General & Administrative | 826.53K | 673.45K | 439.80K |
| Selling & Marketing | 605.01K | 656.93K | -53.69K |
| SG&A | 1.43M | 1.33M | 386.12K |
| Other Expenses | 0.00 | 79.86K | 0.00 |
| Operating Expenses | 1.43M | 1.33M | 386.12K |
| Cost & Expenses | 1.43M | 1.34M | 386.16K |
| Interest Income | 0.00 | 79.86K | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 640.79K | 11.36K | 43.00 |
| EBITDA | -1.37M | -1.25M | -386.12K |
| EBITDA Ratio | -2,108.34% | -1,665.97% | 0.00% |
| Operating Income | -1.37M | -1.34M | -386.16K |
| Operating Income Ratio | -2,108.34% | -1,680.20% | 0.00% |
| Total Other Income/Expenses | -704.86K | 76.88K | 0.00 |
| Income Before Tax | -2.07M | -1.26M | -386.16K |
| Income Before Tax Ratio | -3,195.69% | -1,583.93% | 0.00% |
| Income Tax Expense | 0.00 | -1.00 | -103.23K |
| Net Income | -2.07M | -1.26M | -386.16K |
| Net Income Ratio | -3,195.69% | -1,583.93% | 0.00% |
| EPS | -0.03 | -0.02 | -0.01 |
| EPS Diluted | -0.03 | -0.02 | -0.01 |
| Weighted Avg Shares Out | 76.31M | 66.83M | 66.83M |
| Weighted Avg Shares Out (Dil) | 76.31M | 66.83M | 66.83M |
Source: https://incomestatements.info
Category: Stock Reports